Results 41 to 50 of about 607,470 (403)

Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis

Circulation Research, 2020
Supplemental Digital Content is available in the text. Rationale: Maintaining iron homeostasis is essential for proper cardiac function. Both iron deficiency and iron overload are associated with cardiomyopathy and heart failure via complex mechanisms ...
X. Fang, Zhaoxian Cai, Hao Wang, Dan Han, Qi Cheng, Pan Zhang, F. Gao, Yingying Yu, Zijun Song, Qian Wu, P. An, Sicong Huang, Jianwei Pan, Houzao Chen, Jinghai Chen, A. Linkermann, J. Min, Fudi Wang   +17 more
semanticscholar   +1 more source

Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Prior national data showed a substantial in‐hospital mortality in septal myectomy (SM) with an inverse volume–outcomes relationship. This study sought to assess the contemporary outcomes of septal reduction therapy and volume–outcome ...
Ahmed M. Altibi, Fares Ghanem, Yuanzi Zhao, Miriam Elman, Joaquin Cigarroa, Babak Nazer, Howard K. Song, Ahmad Masri   +7 more
doaj   +1 more source

Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.

Circulation Research, 2020
Anthracycline-based chemotherapy can result in the development of a cumulative and progressively developing cardiomyopathy. Doxorubicin is one of the most highly prescribed anthracyclines in the United States due to its broad spectrum of therapeutic ...
K. Wallace, V. Sardão, P. Oliveira
semanticscholar   +1 more source

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

Circulation: Heart Failure, 2020
Supplemental Digital Content is available in the text.
E. Ammirati, M. Frigerio, E. Adler, C. Basso, D. Birnie, M. Brambatti, M. Friedrich, K. Klingel, J. Lehtonen, J. Moslehi, P. Pedrotti, O. Rimoldi, H. Schultheiss, C. Tschöpe, L. Cooper, P. Camici   +15 more
semanticscholar   +1 more source

CARDIOMYOPATHY: The diagnosis of hypertrophic cardiomyopathy [PDF]

Heart, 2001
Although the pathology of hypertrophic cardiomyopathy (HCM) was first described by French pathologists in the mid 19th century, it remained for the virtually simultaneous reports of Brock and Teare in England some 43 years ago to bring modern attention to this fascinating entity.1 2 Subsequent to these surgical1 and pathological2 observations, there ...
openaire   +3 more sources

Availability and Utilization of Automated External Defibrillators in New York State Schools

Frontiers in Pediatrics, 2021
Background: Use of automated external defibrillators (AEDs) in out-of-hospital cardiac arrests (OHCAs) improve survival. Professional health organizations recommend that AEDs be available in crowded places, including schools but currently only 18 US ...
Milla Arabadjian, Milla Arabadjian, Stephanie Serrato, Mark V. Sherrid   +3 more
doaj   +1 more source

Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile. [PDF]

, 2016
PurposeWe have established a prospective cohort of 1959 patients with chronic Chagas cardiomyopathy to evaluate if a clinical prediction rule based on ECG, brain natriuretic peptide (BNP) levels, and other biomarkers can be useful in clinical practice ...
Bierrenbach, Ana Luiza, Cardoso, Clareci Silva, Cunha-Neto, Edécio, de Oliveira, Lea Campos, Ferreira, Ariela Mota, Ferreira, João Eduardo, Haikal, Desirée Sant'Ana, Oliveira, Claudia Di Lorenzo, Reingold, Arthur L, Ribeiro, Antonio Luiz P, Sabino, Ester Cerdeira   +10 more
core   +3 more sources

CARDIOMYOPATHY: The cardiomyopathies: an overview [PDF]

Heart, 2000
The recent revision (table 1) of the definition of a cardiomyopathy by the World Health Organization1 recognises that ventricular dysfunction can result from a failure to correct volume or pressure overload in valve disease or to control hypertension. Loss of myocardium caused by coronary artery disease also leads to severe ventricular dysfunction. All
openaire   +2 more sources

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

Scientific Reports, 2021
Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investigated the molecular basis of the cardiac phenotype in two mouse models at established disease stage (mouse-HCM), and human myectomy tissue (human-HCM).
Styliani Vakrou, Yamin Liu, Li Zhu, Gabriela V. Greenland, Bahadir Simsek, Virginia B. Hebl, Yufan Guan, Kirubel Woldemichael, Conover C. Talbot, Miguel A. Aon, Ryuya Fukunaga, M. Roselle Abraham   +11 more
doaj   +1 more source

Peripartum Cardiomyopathy

Journal of Education and Teaching in Emergency Medicine, 2023
This simulation is appropriate for emergency medicine (EM) residents of all levels.Peripartum cardiomyopathy (PPCM) is a rare, idiopathic condition that occurs in the mother around the time of childbirth. Heart failure with reduced ejection fraction and/or reduced systolic function diagnosed in patients during the last month of pregnancy or up to five ...
Morris, Victoria L, Mendoza, Carolina, Stevens, Gowri S, Wilson, Jessica L, Kosoko, Adeola A   +4 more
openaire   +4 more sources